Moderna | MRNA - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Amgen USD 9.19B 532M 2026-03
Arrowhead Research USD 613.98M 45.56M 2026-03
Biogen USD 18.65B 394.9M 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Celltrion KRW 434.82B 1.14B 2026-03
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Incyte USD 5.62B 455.37M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Kangmei Pharma CNY 7.31B 84.82M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Moderna USD 7.41B 1.24B 2026-03
Organigram Holdings CAD 371.81M 2.36M 2026-03
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pharma Mar EUR 249.67M 2.16M 2026-03
Puma Biotechnology USD 115.27M 10.55M 2025-09
Qiagen NV USD 3.33B 446.45M 2026-03
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Sartorius EUR 2.82B 96.3M 2026-06
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tilray USD 1.58B 39.08M 2025-09
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
United Therapeutics USD 5.9B 1.2B 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03